Effects of anabolic steroids on acute phase responses in intra-abdominal sepsis by Mealy, K. et al.
Research Paper
Mediators of In￿ammation, 6, 69± 72 (1997)
1997 Rapid Science Publishers
Effects of anabolic steroids on acute
phase responses in intra-abdominal
sepsis
K. Mealy,1,CA A. Clooney,2 P. Marks,1
T. Hennessy1 and J. Jackson2
1Department of Surgery, Trinity College and St
James’s Hospital, Dublin, Ireland; and 3Department
of Immunology, St James’s Hospital and Dublin
Institute of Technology, Dublin, Ireland
Department of Surgery, Western General Hospital,
Crewe Road, Edinburgh EH4 2XU, UK
CA Corresponding Author and Address
Fax: ( 44) 131 343 6529
THE acute phase response is an important adap-
tive response to sepsis and injury. As anabolic
steroids increase protein synthesis we postulated
that these agents might also increase hepatic
acute phase protein synthesis. Male Wistar rats
were pretreated with testosterone or danazol for
48 h prior to caecal ligation and puncture (CLP).
Thirty-six h following surgery the animals were
killed and blood taken for full blood count, total
protein, albumin, a, b and c globulin fractions on
serum electrophoresis, complement C3 and trans-
ferrin levels. Danazol increased the a1, a2 and b1
globulin serum protein fractions in comparison
with no surgery and CLP alone groups. These
results indicate that danazol increases plasma
acute phase proteins, as measured by electro-
phoresis, in this model of intra-abdominal sepsis.
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Introduction
The acute phase response refers to a series of
physiological changes in response to in￿amma-
tion which include pyrexia, anorexia and in-
creased production of plasma acute phase
proteins which are mainly of hepatic origin.1
These proteins include anti-proteases which
limit tissue destruction, and metal binding pro-
teins which are thought to inhibit bacterial
multiplication. In humans, the major positive
acute phase protein is C-reactive protein which
acts as an opsonin and helps in the phagocyto-
sis of foreign particles. Some hepatic acute
phase proteins such as albumin decrease during
in￿ammation and are referred to as negative
acute phase proteins. In rats, the major positive
acute phase proteins are a1-glycoprotein and
a2-macroglobulin while a1 inhibitor 3 is the
major negative acute phase protein.2
The importance of the acute phase response
is highlighted by its persistence during evolu-
tionary history. Sepsis induces a consistent
hepatic acute phase response and in severe
sepsis an adequate hepatic acute phase re-
sponse may be important for survival,3 therefore
manipulation of the acute phase response might
be of bene￿t in improving outcome in sepsis.
This has been shown in the treatment of
fulminant sepsis where the use of recombinant
forms of protease inhibitors such as antithrom-
bin III is an important advance in the therapy of
this disorder.4,5 As major surgery can also be a
trigger for organ failure and life-threatening
sepsis it is possible that augmentation of acute
phase responses prior to surgery may be of
bene￿t in surgical patients.
In these studies we examined the role of the
androgenic steroids testosterone and danazol,
which are known to increase skeletal muscle
protein synthesis, in augmenting hepatic acute
phase proteins in an animal model of intra-
abdominal sepsis.
Materials and Methods
Male Wistar rats were randomized into ￿ve
groups. Three groups underwent caecal ligation
and puncture (CLP) and a fourth group under-
went sham operation (n 12): all under neuro-
leptic anaesthesia (ketamine/xylazine). A CLP
alone group received CLP and no treatment
(n 9) and the two other CLP groups received
either testosterone (Test, n 12, 2.5 mg testo-
sterone propionate) or danazol (Dan, n 12,
20 mg/kg/day). Post-operative analgesia was
administered as necessary by subcutaneous
injection (buprenorphine hydrocloride). The
testosterone was administered as a single depot
injection 48 h prior to surgery and the danazol
was given by gavage, twice daily for 48 h before
surgery and following surgery until the end of
Mediators of In¯ ammation ´ Vol 6 ´ 1997 69the study period. The animals were killed 36 h
following surgery as in our laboratory this CLP
model has a mortality of approximately 20%at
48 h. All animals were allowed rat chow and
water ad libitum. The ￿fth group underwent
no surgery or treatment (n 6).
The animals were killed by CO2 inhalation
and exsanguinated by cardiac puncture. Blood
was taken into EDTA bottles for full blood count
and serum was also obtained for total protein
estimation and serum electrophoresis. Full
blood counts were performed on a Coulter
STKS Automated Haematology Analyzer and
differential white cell counts performed manu-
ally following Giemsa staining of blood ￿lms.
T otal serum protein was measured by refracto-
metry and albumin, a, b and c globulin frac-
tions were measured by electrophoresis
followed by scanning densitometry. The a and
b globulin fractions were subdivided into a1
and a2 and b1 and b2 groups for quanti￿cation.
Transferrin and complement C3 levels were
measured by laser nephalometry.
Results
Survival
There were no treatment associated deaths
during the 36 h study period in any of the
animal groups.
Full blood count
Differences in full blood counts between the
groups are shown in Table 1. There was a fall in
both total white cell and platelet counts in all
the CLP groups in comparison with the no
surgery and sham groups. The CLP and testo-
sterone administered group had the greatest fall
in platelet count which was signi￿cantly less
than both the CLP alone and the CLP and
danazol groups.
Total protein
There was a signi￿cant fall in total protein
values in all the CLP groups, irrespective of
testosterone or danazol treatment, in com-
parison with the no surgery or sham groups
(Table 2).
Measurement of acute phase
proteins
Figure 1 illustrates the typical changes observed
in the serum electrophoresis pro￿les of a
control rat and a rat following CLP . A fall in
albumin levels occurred in all CLP groups in
comparison with the no surgery and sham
groups. As shown in Table 2, the a1 proteins
fell in the CLP alone and CLP and testosterone
groups in comparison with the control groups.
Table 1. Full blood count results in the different animal groups at the end of the study period
No surgery
(n 6)
Sham
(n 9)
CLP alone
(n 9)
CLP Test
(n 12)
CLP Dan
(n 12)
White cell count (3 109/l) 7.9 0.4 7.14 0.8 4.8 0.59 5.3 0.5 6.3 0.8
Platelets (3 109/l) 959 23 848 34 697 39 445 41 , , 654 47
Neutrophils (%) 18.8 1.7 16.14 3.4 14.7 1.9 19.2 1.8 19.7 4.2
Lymphocytes (%) 80 1.4 82 3.5 79 2.6 79.3 1.8 78.5 4.3
Monocytes (%) 1.8 0.2 1.8 0.3 2 1 1.5 0.2 1.6 0.4
P , 0.05 from No surgery and Sham groups; P , 0.01 from No surgery and Sham; P , 0.01 from CLP alone; P , 0.01 from CLP Dan.
Table 2. Total protein, albumin and the a1, a2, b1, b2 and c globulin fractions on electrophoresis in the different animal
groups
No surgery
(n 6)
Sham
(n 9)
CLP alone
(n 9)
CLP Test
(n 12)
CLP Dan
(n 12)
Total protein (g/l) 54.7 2.3 50.5 1.7 43.4 3.2 39.5 2.3 43.5 1.8 ,
Albumin (g/l) 27.7 1.2 22.7 1.4 13.8 1.4 15.5 1.2 14.8 0.5
a1 (g/l) 9.6 0.6 8.8 0.5 5.9 0.7 8.1 0.8 10.1 1.1
a2 (g/l) 4.1 0.4 5.4 0.4 4.3 0.5 5.5 0.5 5.6 0.6
b1 (g/l) 2.3 0.2 2.8 0.3 2.1 0.5 1.8 0.2 3.4 0.5
b2 (g/l) 7.1 0.4 7.5 0.5 5.8 0.8 6.5 0.4 6.9 0.3
c (g/l) 2.5 0.4 2.9 0.4 2.4 0.7 1.9 0.3 2.4 0.6
Complement C3 (g/l) 0.41 0.03 0.42 0.04 0.38 0.04 0.32 0.03 0.36 0.03
Transferrin (g/l) 0.62 0.01 0.78 0.04 0.74 0.04 0.7 0.03 0.7 0.03
P , 0.05, P , 0.01, P , 0.001 from No surgery and Sham groups; P , 0.05, P , 0.01 from CLP alone; P , 0.05 from CLP Test.
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group in which levels of the a1 protein fraction
were signi￿cantly greater than the CLP alone
group. Danazol administration also tended to
increase the a2, b1 and b2 proteins in compari-
son with the CLP alone and CLP and testoster-
one groups. There was no change in the c
protein fraction or the complement C3 levels
between any of the groups. Transferrin levels
tended to rise in the sham group and all of the
CLP groups in comparison with the no surgery
group, although these differences were not
signi￿cant.
Discussion
In this model of caecal ligation and puncture,
surgery and sepsis induces a profound change
in the plasma protein pro￿les of the rat (Fig. 1).
When these results are analysed qualitatively it
is clear that danazol, a derivative of the syn-
thetic steroid 17-ethynl testosterone increases
plasma acute phase proteins as measured by
increased a1, a2 and b1 protein fractions on
serum electrophoresis. Similar but less impress-
ive trends were also observed with testosterone
proprionate.
The levels of a1 inhibitor 3 (a1I3), the major
negative acute phase protein in the rat, was
maintained in this study by danazol. In contrast,
in the CLP alone and the CLP and testosterone
groups a1 levels fell, implying that danazol
either inhibited the fall in this negative acute
phase protein or increased other positive acute
phase proteins in this band. In addition, these
results show that danazol also increased the a2
band on electrophoresis suggesting that a2-
macroglobulin levels, the major rat positive
acute phase protein and contained in this band,
was also increased. While serum electrophoresis
gives a useful indication of serum protein
changes induced by treatment in these studies,
characterization of individual acute phase pro-
teins require further study.
Little information is available regarding the
clinical importance of appropriate acute phase
responses to in￿ammation. However, the highly
conserved nature of the major acute phase
proteins implies a signi￿cant survival advantage.
Furthermore, many of the acute phase proteins
are protease inhibitors and are presumed to be
essential in modifying the major life-threatening
side effects of sepsis and tissue trauma. Domin-
ioni and colleagues have demonstrated that
acute phase responses are indicative of out-
come in severe sepsis.3 In a series of 135
patients with surgical infections, patients with
low a± 1-acid glycoprotein, a± 1-antitrypsin,
complement factor B and C3 levels at presenta-
tion had a higher mortality.
Recombinant protease inhibitors can be used
effectively in the treatment of sepsis. Guerrero
and co-workers have shown that administration
of C1 esterase inhibitor prevents the pulmonary
and cardiovascular dysfunction associated with
endotoxic shock.6 Dickneite and Seiffge have
demonstrated that C1 esterase inhibitor pre-
vents the vascular leak syndrome in the sys-
temic in￿ammatory response syndrome (SIRS)
induced in rats by interleukin-2.7 In humans,
Hack and colleagues have also shown that C1-
esterase inhibitor administration appear to be of
bene￿t in septic patients.8 These studies pro-
vide evidence that exogenous administration of
acute phase proteins might, therefore, be of
bene￿t in patients with sepsis.
An alternative approach arises from our work
demonstrating the induction of acute phase
proteins using danazol. Danazol is known to
induce C1-esterase levels and is used clinically
in angiooedema, a C1-esterase inhibitor de￿-
cient state.9 Endogenous induction of C1-ester-
ase inhibitor levels using danazol would have
both medical and economic advantages.
Furthermore, our work demonstrates that ana-
bolic steroids may offer the potential in the
prophylactic treatment of subjects at increased
risk of sepsis. The effectiveness of danazol in
inducing increased acute phase protein levels
and altering physiological and clinical para-
FIG. 1. Electrophoresis strips from a normal rat (C) and a
rat following CLP (T) are shown. The arrows indicate in
sequence from above down, diminished albumin, a de-
crease in the a1 and an increase in the a2 bands and an
increase in the b1 band respectively.
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